101 related articles for article (PubMed ID: 27405370)
1. Prescription Opioids. V. Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration.
DePriest AZ; Heltsley R; Black DL; Mitchell JM; LoDico C; Flegel R; Cone EJ
J Anal Toxicol; 2016 Oct; 40(8):566-574. PubMed ID: 27405370
[TBL] [Abstract][Full Text] [Related]
2. Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.
Cone EJ; Heltsley R; Black DL; Mitchell JM; Lodico CP; Flegel RR
J Anal Toxicol; 2013 Jun; 37(5):255-64. PubMed ID: 23609023
[TBL] [Abstract][Full Text] [Related]
3. Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration.
DePriest AZ; Heltsley R; Black DL; Mitchell JM; LoDico C; Flegel R; Cone EJ
J Anal Toxicol; 2016 Oct; 40(8):575-582. PubMed ID: 27405368
[TBL] [Abstract][Full Text] [Related]
4. Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration.
Cone EJ; DePriest AZ; Heltsley R; Black DL; Mitchell JM; LoDico C; Flegel R
J Anal Toxicol; 2015 Apr; 39(3):192-202. PubMed ID: 25589778
[TBL] [Abstract][Full Text] [Related]
5. Prescription opioids. II. Metabolism and excretion patterns of hydrocodone in urine following controlled single-dose administration.
Cone EJ; Heltsley R; Black DL; Mitchell JM; Lodico CP; Flegel RR
J Anal Toxicol; 2013 Oct; 37(8):486-94. PubMed ID: 23946451
[TBL] [Abstract][Full Text] [Related]
6. Observations of urinary oxycodone and metabolite distributions in pain patients.
Elder NM; Atayee RS; Best BM; Ma JD
J Anal Toxicol; 2014 Apr; 38(3):129-34. PubMed ID: 24523296
[TBL] [Abstract][Full Text] [Related]
7. Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases.
Pantano F; Brauneis S; Forneris A; Pacifici R; Marinelli E; Kyriakou C; Pichini S; Busardò FP
Clin Chem Lab Med; 2017 Aug; 55(9):1324-1331. PubMed ID: 28080998
[TBL] [Abstract][Full Text] [Related]
8. Observations on the urine metabolic ratio of oxymorphone to oxycodone in pain patients.
Yee DA; Best BM; Atayee RS; Pesce AJ
J Anal Toxicol; 2012 May; 36(4):232-8. PubMed ID: 22511697
[TBL] [Abstract][Full Text] [Related]
9. Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications.
Fang WB; Lofwall MR; Walsh SL; Moody DE
J Anal Toxicol; 2013; 37(6):337-44. PubMed ID: 23743505
[TBL] [Abstract][Full Text] [Related]
10. Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives.
Cone EJ; Zichterman A; Heltsley R; Black DL; Cawthon B; Robert T; Moser F; Caplan YH
Forensic Sci Int; 2010 May; 198(1-3):58-61. PubMed ID: 20036472
[TBL] [Abstract][Full Text] [Related]
11. Rapid quantification of urinary oxycodone and oxymorphone using fast gas chromatography-mass spectrometry.
McKinley S; Snyder JJ; Welsh E; Kazarian CM; Jamerson MH; Klette KL
J Anal Toxicol; 2007 Oct; 31(8):434-41. PubMed ID: 17988456
[TBL] [Abstract][Full Text] [Related]
12. Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.
Heltsley R; Zichterman A; Black DL; Cawthon B; Robert T; Moser F; Caplan YH; Cone EJ
J Anal Toxicol; 2010; 34(1):32-8. PubMed ID: 20109300
[TBL] [Abstract][Full Text] [Related]
13. Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.
Smith ML; Hughes RO; Levine B; Dickerson S; Darwin WD; Cone EJ
J Anal Toxicol; 1995; 19(1):18-26. PubMed ID: 7536861
[TBL] [Abstract][Full Text] [Related]
14. Urine drug testing for oxycodone and its metabolites as a tool for drug-drug interactions?
Mikus G
J Anal Toxicol; 2015; 39(1):81-2. PubMed ID: 25288721
[No Abstract] [Full Text] [Related]
15. Response to urine drug testing for oxycodone and its metabolites as a tool for drug-drug interactions.
Elder NM; Atayee RS; Best BM; Ma JD
J Anal Toxicol; 2015; 39(1):80. PubMed ID: 25288719
[No Abstract] [Full Text] [Related]
16. Evaluation of the DRI oxycodone immunoassay for the detection of oxycodone in urine.
Backer RC; Monforte JR; Poklis A
J Anal Toxicol; 2005 Oct; 29(7):675-7. PubMed ID: 16419399
[TBL] [Abstract][Full Text] [Related]
17. Degradation of Opioids and Opiates During Acid Hydrolysis Leads to Reduced Recovery Compared to Enzymatic Hydrolysis.
Sitasuwan P; Melendez C; Marinova M; Mastrianni KR; Darragh A; Ryan E; Lee LA
J Anal Toxicol; 2016 Oct; 40(8):601-607. PubMed ID: 27702939
[TBL] [Abstract][Full Text] [Related]
18. Uncertainty in assessing impact of drug-drug interactions on oxycodone metabolite patterns.
DePriest AZ; Puet BL; Heltsley R; Robert T; Black DL
J Anal Toxicol; 2014 Sep; 38(7):462. PubMed ID: 24986837
[No Abstract] [Full Text] [Related]
19. Suitability of the DRI Hydrocodone/Hydromorphone Immunoassay in the Clinical Environment at a Lower Cutoff: Validation With LC-MS/MS Analysis.
Dixon RB; Dasgupta A
Ther Drug Monit; 2016 Dec; 38(6):787-790. PubMed ID: 27764026
[TBL] [Abstract][Full Text] [Related]
20. Hydrophilic interaction LC-MS/MS analysis of opioids in urine: significance of glucuronide metabolites.
French D; Wu A; Lynch K
Bioanalysis; 2011 Dec; 3(23):2603-12. PubMed ID: 22136049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
